Attached files
file | filename |
---|---|
EX-32.1 - EX-32.1 - Redpoint Bio CORP | a11-14007_3ex32d1.htm |
EXCEL - IDEA: XBRL DOCUMENT - Redpoint Bio CORP | Financial_Report.xls |
EX-32.2 - EX-32.2 - Redpoint Bio CORP | a11-14007_3ex32d2.htm |
United States
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
(Mark One)
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2011
Or
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number: 000-51708
Redpoint Bio Corporation
(Exact name of Registrant as specified in its charter)
Delaware |
|
22-3393959 |
(State or other jurisdiction of |
|
(I.R.S. Employer Identification No.) |
incorporation or organization) |
|
|
7 Graphics Drive, Ewing, New Jersey 08628
(Address of principal executive offices) (Zip Code)
(609) 637-9700
(Registrants Telephone Number, Including Area Code)
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of large accelerated filer, accelerated filer, and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer o |
|
Accelerated filer o |
|
|
|
Non-accelerated filer o |
|
Smaller reporting company x |
(Do not check if a smaller reporting company) |
|
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
The number of shares of the registrants common stock outstanding as of September 12, 2011 was 79,914,789.
EXPLANATORY NOTE
Redpoint Bio Corporation (the Company) is filing this Amendment No. 1 to its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2011 (the Form 10-Q) as an exhibit only filing in order to comply with certain XBRL filing requirements in accordance with Rule 405 of Regulation S-T. This Amendment No. 1 to Quarterly Report on Form 10-Q/A (this Amendment) is being filed solely to amend the Exhibit Index included in the Form 10-Q. In addition, as required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended, new certifications by our principal executive officer and principal financial officer are filed as exhibits to this Amendment.
Except as described above, this Amendment does not reflect events occurring after the filing of the original Form 10-Q and no revisions are being made pursuant to this Amendment to the Companys financial statements or any other disclosure contained in the Form 10-Q.
Exhibit No. |
|
|
|
|
|
10.1 |
|
Discounted Payoff Agreement, by and between Redpoint Bio Corporation and CIT Healthcare LLC, dated May 11, 2011 (Incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K, dated May 11, 2011, and filed on May 12, 2011). |
|
|
|
32.1 |
|
Certification of principal executive officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith). |
|
|
|
32.2 |
|
Certification of principal accounting and financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith). |
|
|
|
101.INS |
|
XBRL Instance Document* |
|
|
|
101.SCH |
|
XBRL Taxonomy Extension Schema Document* |
|
|
|
101.CAL |
|
XBRL Taxonomy Extension Calculation Linkbase Document* |
|
|
|
101.DEF |
|
XBRL Taxonomy Extension Definition Linkbase Document* |
|
|
|
101.LAB |
|
XBRL Taxonomy Extension Label Linkbase Document* |
|
|
|
101.PRE |
|
XBRL Taxonomy Extension Presentation Linkbase Document* |
* Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
REDPOINT BIO CORPORATION | |
|
|
|
September 14, 2011 |
By: |
/s/ F. Raymond Salemme |
|
|
F. Raymond Salemme |
|
|
President and Chief Executive Officer |
|
|
(Principal Executive Officer) |
|
|
|
September 14, 2011 |
By: |
/s/ Scott M. Horvitz |
|
|
Scott M. Horvitz |
|
|
Chief Financial Officer, Treasurer and Secretary |
|
|
(Principal Financial and Accounting Officer) |
EXHIBIT INDEX
Exhibit No. |
|
|
|
|
|
10.1 |
|
Discounted Payoff Agreement, by and between Redpoint Bio Corporation and CIT Healthcare LLC, dated May 11, 2011 (Incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K, dated May 11, 2011, and filed on May 12, 2011). |
|
|
|
32.1 |
|
Certification of principal executive officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith). |
|
|
|
32.2 |
|
Certification of principal accounting and financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith). |
|
|
|
101.INS |
|
XBRL Instance Document* |
|
|
|
101.SCH |
|
XBRL Taxonomy Extension Schema Document* |
|
|
|
101.CAL |
|
XBRL Taxonomy Extension Calculation Linkbase Document* |
|
|
|
101.DEF |
|
XBRL Taxonomy Extension Definition Linkbase Document* |
|
|
|
101.LAB |
|
XBRL Taxonomy Extension Label Linkbase Document* |
|
|
|
101.PRE |
|
XBRL Taxonomy Extension Presentation Linkbase Document* |
* Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.